Recurrent vulvovaginal candidiasis (RVVC) is defined as four or more episodes of thrush within 12 months. It is more common than many women realise and can persist for years despite repeated antifungal treatment. If you have had repeated episodes, it is worth confirming that each episode is actually candidiasis through testing, rather than assuming every recurrence is thrush symptoms from other vaginal conditions can present similarly.

Symptoms include thick white discharge often described as cottage cheese-like, intense vulval itching or burning, redness and soreness of the vulva and vaginal area, and discomfort during sex or urination. Symptoms can range from mild to significantly disruptive.

Thrush and BV can overlap in symptoms but they often present differently. Thrush more commonly causes vulval itching, burning, redness and soreness, sometimes with thick white discharge. BV more commonly causes thin discharge and a noticeable fishy odour, particularly after sex. However, symptoms alone cannot reliably distinguish the two — particularly when symptoms are recurrent or persistent. If symptoms continue despite treatment, testing and consideration of other causes is appropriate.

Standard antifungal treatments target Candida albicans, the most common species. However, some women have recurrent infections caused by non-albicans Candida species, which can be resistant to first-line antifungals. Without species identification through testing, the wrong treatment may be used repeatedly.

Yes. Hormonal changes — including those associated with the menstrual cycle, pregnancy, oral contraceptives and perimenopause — can alter vaginal pH and create conditions that favour Candida overgrowth. Many women notice thrush flares at predictable points in their cycle.

Candida can be found on the skin of sexual partners and may be transmitted during sexual contact in some cases. However, sexual transmission is not the primary driver of recurrent thrush for most women. Recurrence is more commonly related to endogenous factors — including gastrointestinal Candida carriage, vaginal microbiome disruption, and the formation of Candida biofilms.

Candida biofilms are an area of active research. Laboratory studies suggest that biofilm formation may contribute to antifungal tolerance, making the organism harder to eradicate in controlled settings. However, the clinical significance of biofilms in recurrent vulvovaginal candidiasis is still being investigated, and it is not yet established as a confirmed mechanism in routine clinical practice. It is one factor that may be relevant for some women with persistent symptoms.

Some women report that dietary factors particularly high sugar intake appear to influence their symptoms. Elevated blood glucose, including undiagnosed or poorly managed diabetes, is a recognised contributing factor in recurrent thrush. The evidence for specific anti-Candida diets is limited, but maintaining stable blood glucose is clinically relevant.

Lactobacillus species are an important part of the vaginal microbiome and can contribute to an environment that limits the overgrowth of some organisms, including Candida. Changes in the vaginal microbiome may be relevant in some women with recurrent symptoms, although the relationship between microbiome composition and recurrent thrush is not fully established and may vary between individuals.

Yes. Antibiotic use disrupts the vaginal microbiome by reducing protective Lactobacillus bacteria, creating conditions where Candida can overgrow. Women who experience thrush following antibiotic courses may have a more sensitive vaginal microbiome that warrants further assessment.

Aerobic vaginitis is a distinct vaginal condition caused by aerobic bacteria — not Candida. It can produce discharge and irritation that resembles thrush, and is frequently misdiagnosed. If thrush treatments keep failing, aerobic vaginitis should be considered and tested for.

You should seek assessment if you experience four or more episodes within 12 months, if symptoms persist despite antifungal treatment, if over-the-counter treatments are no longer effective, or if you are unsure whether your symptoms are due to thrush. Recurrent thrush warrants investigation beyond repeated prescriptions.

Yes. Recurrent thrush can be associated with conditions such as diabetes, immune dysfunction, skin conditions affecting the vulva, and concurrent vaginal infections. A comprehensive assessment helps identify whether additional factors are contributing.

Testing can be valuable in recurrent cases, particularly vaginal swabs to identify the Candida species present and confirm the diagnosis. In recurrent or treatment-resistant cases, vaginal culture and Candida speciation can be important — non-albicans species may respond differently to standard treatments, and identifying the species present helps ensure the most appropriate approach is taken.

Candida can be detected on vaginal swabs in women who have no symptoms. This is known as asymptomatic colonisation and is relatively common — Candida is a commensal organism that can be present in the vagina without necessarily causing infection or discomfort. Treatment is generally recommended when symptoms are present, rather than on the basis of a positive swab result alone. If you have a positive result but no current symptoms, this is worth discussing with your clinician to determine whether any management is indicated in your individual circumstances.

No. You do not need a GP referral to book a consultation with Kylie Sayce NP. You can book directly online.

Yes. As an Endorsed Nurse Practitioner, Kylie has prescribing authority and can prescribe antifungal and other medications where clinically appropriate.

Consultations are conducted via secure video or phone telehealth from anywhere in Australia. A consultation typically covers your symptom history and recurrence patterns, previous treatments and how you responded, vaginal microbiome health, hormonal influences, and other contributing factors. The aim is to understand what is driving your recurrence and develop a personalised management plan, not just another prescription.

Telehealth is suitable for many women with recurrent vaginal symptoms, and most consultations can be completed without an in-person visit. However, some presentations require physical or gynaecological examination, specialist review, or investigations that cannot be appropriately assessed remotely. Where this applies, I will recommend appropriate face-to-face care or referral — your safety and a thorough assessment always take priority.